Beyond The Numbers: 4 Analysts Discuss Puma Biotechnology Stock
Beyond The Numbers: 4 Analysts Discuss Puma Biotechnology Stock
數字之外：4位分析師討論puma biotechnology股票
Ratings for Puma Biotechnology (NASDAQ:PBYI) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
在過去的三個月中，有4名分析師對puma biotechnology（納斯達克:PBYI）進行了評級，展示了看好和看淡的混合觀點。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表總結了他們最近的評級，展示了過去30天內不斷變化的情緒，並將其與前幾個月進行了比較。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $7.0, a high estimate of $7.00, and a low estimate of $7.00. This current average has not changed from the previous average price target.
分析師通過他們對12個月目標價的評估提供更深入的見解，揭示了7.0美元的平均目標價、7.00美元的高估值和7.00美元的低估值。當前的平均值與前一個平均價格目標相同。
Interpreting Analyst Ratings: A Closer Look
解讀分析師評級：更深入的了解
The standing of Puma Biotechnology among financial experts is revealed through an...
通過對最近分析師行爲的深...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。